Biography:
Leveraging over six years of research experience, Swarandeep Singh specialize in HIV-1 vaccine design and monoclonal antibody discovery, focusing on nanoparticle-based vaccines in preclinical models. He have published eight peer-reviewed articles with 79 citations and hold an H-index of 5, along with a patent. As a reviewer for leading journals and a member of various scientific societies, he committed to advancing research. My achievements include the HIV Research Trust Scholarship and IAS Scholarship, reflecting global recognition. Recently honored as an IAVI Advanced Leadership member, he remain dedicated to impactful contributions in vaccine design and infectious disease therapeutics.
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer